Publication | Closed Access

Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium

InflammationAnti-inflammatorySignal TransductionMedicineImmunologyAutophagyCell DeathChronic InflammationVascular BiologyAstragaloside IvPharmacologyCell BiologyCell Signaling